Question 1

What are the potential benefits of participating in this trial for my allergic conjunctivitis?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. clinical trial (NCT03479307). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Bilastine compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. clinical trial (NCT03479307). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with Bilastine and Zaditen?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. clinical trial (NCT03479307). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. clinical trial (NCT03479307). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. clinical trial (NCT03479307). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific medications or treatments I need to avoid while in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. clinical trial (NCT03479307). Contact the study team or your healthcare provider for specific answers.

What this study is about